Lanka 2014.

Study characteristics
Methods	RCT
Participants	Inclusion: GA > 28 weeks, singletons, intact membranes, absence of labour, cephalic presentation, BS < 5. Exclusion: multifetal gestations, congenital malformations, Gravidity > 4, non‐reassuring FHR trace, ruptured membranes, active genital infection, previous uterine surgery (including CS), low‐lying placenta, chorioamnionitis, EFW > 4000 g, IUFD, known allergies to latex or PGs
Interventions	Foley + misoprostol (n = 63): 16F Foley catheter, 30 cc, traction applied, max 12 hours ‐ 25 mcg vaginal misoprostol, every 4 hours up to a max of 8 doses. vaginal misoprostol (n = 63): 25 mcg vaginal misoprostol every 4 hours, with a max of 8 doses
Outcomes	induction to delivery interval, rate of vaginal deliveries, hyperstimulation, CS rate, neonatal outcome, chorioamnionitis, oxytocin use
Notes	Setting: tertiary care centre, India Study period: 2‐year period Funding: no funding Declarations of interest: none declared
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Computer‐generated sequence, block randomisation
Allocation concealment (selection bias)	Low risk	Sequentially‐numbered opaque, sealed envelopes
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Not feasible due to nature of intervention
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not reported
Incomplete outcome data (attrition bias) All outcomes	Low risk	ITT analysis, no missing data or cases
Selective reporting (reporting bias)	Low risk	All pre‐specified outcomes were reported in results
Other bias	Low risk	No other bias detected